ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Cosentyx 300 mg / 2 ml, Injektionslösung in einer Fertigspritze - 
65225003 PPNovartis Pharma Schweiz AG
Cosentyx 300 mg / 2 ml, Injektionslösung in einer Fertigspritze20.02.2015
  03.02.2022
Secukinumab (L04AC10) 
WHO-DDD 
07.15. 
07.15. 
B  
Yes 
IPCI
1074.57Yes
    
10 %1185.10
7680652250034Biotechnologika
  
Composition
secukinumabum 300.0 mg, trehalosum dihydricum, histidinum, histidini hydrochloridum monohydricum, methioninum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 2 ml.
Packungsbestandteile
Injection solution in prefilled syringe 
  
 
Active AgentDose
Secukinumabum300mg / 2ml
BAG: Active AgentDose
Secukinumabum300 mg
 
Inactive agents
Histidin Hydrochloride Monohydrate
Histidine
Methionine
Polysorbatum 80
Trehalosum Dihydricum
 
Source
Data was imported : 05.09.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home